CLOROX CO /DE/
Business
The Clorox Company is a multinational manufacturer and marketer of consumer and professional cleaning, household and personal care products. It offers branded bleach, cleaning and disinfecting products; bags and wraps; cat litter; grilling and food products; water-filtration and natural personal care items, sold under names such as Clorox, Pine-Sol, Glad, Fresh Step, Kingsford, Hidden Valley, Brita and Burt’s Bees, and professional lines like CloroxPro and Clorox Healthcare. The company reports four operating segments: Health and Wellness, Household, Lifestyle and International. Its products are sold globally through mass retailers, grocery outlets, warehouse clubs, dollar and home‑hardware stores, drug and specialty channels, direct and third‑party e-commerce, distributors, subsidiaries, licensees and joint ventures.
Summary from filing dated 2025-08-08
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 7,104 | 7,093 | 7,389 | 7,107 | 7,341 | |
| Cost of products sold | 3,891 | 4,045 | 4,481 | 4,562 | 4,142 | |
| Gross profit | 3,213 | 3,048 | 2,908 | 2,545 | 3,199 | |
| Selling and administrative expenses | 1,124 | 1,167 | 1,183 | 954 | 1,004 | |
| Advertising costs | 770 | 832 | 734 | 709 | 790 | |
| Research and development costs | 121 | 126 | 138 | 132 | 149 | |
| Loss on divestiture | 118 | 240 | 0 | 0 | — | |
| Pension settlement charge | 0 | 171 | 0 | 0 | — | |
| Goodwill, trademark and other asset impairments | 0 | 0 | 445 | 0 | 329 | |
| Interest expense | 88 | 90 | 90 | 106 | 99 | |
| Other (income) expense, net | −86 | 24 | 80 | 37 | −72 | |
| Earnings before income taxes | 1,078 | 398 | 238 | 607 | 900 | |
| Income taxes | 254 | 106 | 77 | 136 | 181 | |
| Net earnings | 824 | 292 | 161 | 471 | 719 | |
| Less: Net earnings attributable to noncontrolling interests | 14 | 12 | 12 | 9 | 9 | |
| Net earnings attributable to Clorox | 810 | 280 | 149 | 462 | 710 | |
| Basic net earnings per share (in dollars per share) | 6.56 | 2.26 | 1.21 | 3.75 | 5.66 | |
| Diluted net earnings per share (in dollars per share) | 6.52 | 2.25 | 1.2 | 3.73 | 5.58 | |
| Basic (in shares) | 124 | 124 | 124 | 123 | 126 | |
| Diluted (in shares) | 124 | 125 | 124 | 124 | 127 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 167 | 202 | 367 | 183 | 319 | |
| Receivables, net | 821 | 695 | 688 | 681 | 604 | |
| Inventories, net | 523 | 637 | 696 | 755 | 752 | |
| Prepaid expenses and other current assets | 97 | 88 | 77 | 106 | 154 | |
| Total current assets | 1,608 | 1,622 | 1,828 | 1,725 | 1,829 | |
| Property, plant and equipment, net | 1,267 | 1,315 | 1,345 | 1,334 | 1,302 | |
| Operating lease right-of-use assets | 333 | 360 | 346 | 342 | 332 | |
| Goodwill | 1,229 | 1,228 | 1,252 | 1,558 | 1,575 | |
| Trademarks, net | 502 | 538 | 543 | 687 | 693 | |
| Other intangible assets, net | 64 | 143 | 169 | 197 | 225 | |
| Other assets | 558 | 545 | 462 | 315 | 378 | |
| Total assets | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 | |
| Notes and loans payable | 4 | 4 | 50 | 237 | 0 | |
| Current operating lease liabilities | 87 | 84 | 87 | 78 | 81 | |
| Accounts payable and accrued liabilities | 1,828 | 1,486 | 1,659 | 1,469 | 1,675 | |
| Total current liabilities | 1,919 | 1,574 | 1,917 | 1,784 | 2,056 | |
| Long-term debt | 2,484 | 2,481 | 2,477 | 2,474 | 2,484 | |
| Long-term operating lease liabilities | 305 | 334 | 310 | 314 | 301 | |
| Other liabilities | 351 | 848 | 825 | 791 | 834 | |
| Deferred income taxes | 20 | 22 | 28 | 66 | 67 | |
| Total liabilities | 5,079 | 5,259 | 5,557 | 5,429 | 5,742 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2025 and 2024; and 122,694,263 and 124,201,807 shares outstanding as of June 30, 2025 and 2024, respectively | 131 | 131 | 131 | 131 | 131 | |
| Additional paid-in capital | 1,319 | 1,288 | 1,245 | 1,202 | 1,186 | |
| Retained earnings | 432 | 250 | 583 | 1,048 | 1,036 | |
| Treasury stock, at cost: 8,047,198 and 6,539,654 shares as of June 30, 2025 and 2024, respectively | −1,404 | −1,186 | −1,246 | −1,346 | −1,396 | |
| Accumulated other comprehensive net (loss) income | −157 | −155 | −493 | −479 | −546 | |
| Total Clorox stockholders equity | 321 | 328 | 220 | 556 | 411 | |
| Noncontrolling interests | 161 | 164 | 168 | 173 | 181 | |
| Total stockholders equity | 482 | 492 | 388 | 729 | 592 | |
| Total liabilities and stockholders equity | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 219 | 235 | 236 | 224 | 211 | |
| Stock-based compensation | 81 | 74 | 73 | 52 | 50 | |
| Deferred income taxes | −18 | −100 | −149 | 5 | −32 | |
| Loss on divestiture | 112 | 238 | 0 | 0 | — | |
| Other | −26 | 26 | 38 | 19 | 10 | |
| Receivables, net | −145 | −34 | −13 | −84 | 82 | |
| Inventories, net | 63 | 55 | 58 | −18 | −282 | |
| Prepaid expenses and other current assets | −9 | 25 | −1 | 16 | −30 | |
| Accounts payable and accrued liabilities | −124 | −140 | 157 | −47 | 311 | |
| Operating lease right-of-use assets and liabilities, net | 2 | 0 | 1 | −1 | −2 | |
| Income taxes payable/prepaid | 2 | −147 | 152 | 35 | −90 | |
| Net cash provided by operations | 981 | 695 | 1,158 | 786 | 1,276 | |
| Capital expenditures | −220 | −212 | −228 | −251 | −331 | |
| Proceeds from divestiture, net of cash divested | 128 | 17 | 0 | 0 | — | |
| Other | −2 | 20 | 5 | 22 | −36 | |
| Net cash used for investing activities | −94 | −175 | −223 | −229 | −452 | |
| Notes and loans payable, net | 0 | −45 | −188 | 237 | 0 | |
| Treasury stock purchased | −332 | 0 | 0 | −25 | −905 | |
| Cash dividends paid to Clorox stockholders | −602 | −595 | −583 | −571 | −558 | |
| Cash dividends paid to noncontrolling interests | −16 | −16 | −15 | −15 | −31 | |
| Issuance of common stock for employee stock plans and other | 26 | 1 | 33 | 5 | 103 | |
| Net cash used for financing activities | −924 | −655 | −753 | −689 | −1,391 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | −26 | 0 | −6 | 12 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | −37 | −161 | 182 | −138 | −555 | |
| Interest paid | 97 | 102 | 99 | 89 | 89 | |
| Income taxes paid, net of refunds | 264 | 347 | 73 | 100 | 303 |